Global Infantile Spasms Therapeutics Market Growth (Status and Outlook) 2025-2031

March 2025 | 95 pages | ID: G319CF55B1F4EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The global Infantile Spasms Therapeutics market size is predicted to grow from US$ 154 million in 2025 to US$ 192 million in 2031; it is expected to grow at a CAGR of 3.7% from 2025 to 2031.

An infantile spasm (IS), also known as West Syndrome, is a specific type of seizure seen in an epilepsy syndrome of infancy and childhood. West Syndrome is characterized by infantile spasms, developmental regression, and a specific pattern on electroencephalography (EEG) testing called hypsarrhythmia (chaotic brain waves). The onset of infantile spasms is usually in the first year of life, typically between 4-8 months. The seizures primarily consist of a sudden bending forward of the body with stiffening of the arms and legs; some children arch their backs as they extend their arms and legs. The condition is usually observed in 2% of childhood epilepsies and 25% of epilepsies that start in the first year of life.

Global Infantile Spasms Therapeutics key players include Mallinckrodt, H. Lundbeck, etc. Global top two manufacturers hold a share over 60%.

In terms of product, Oral is the largest segment, with a share obout 55%. And in terms of application, the largest application is Hospital, followed by Clinic, etc.

LPI (LP Information)' newest research report, the “Infantile Spasms Therapeutics Industry Forecast” looks at past sales and reviews total world Infantile Spasms Therapeutics sales in 2024, providing a comprehensive analysis by region and market sector of projected Infantile Spasms Therapeutics sales for 2025 through 2031. With Infantile Spasms Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Infantile Spasms Therapeutics industry.

This Insight Report provides a comprehensive analysis of the global Infantile Spasms Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Infantile Spasms Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Infantile Spasms Therapeutics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Infantile Spasms Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Infantile Spasms Therapeutics.

This report presents a comprehensive overview, market shares, and growth opportunities of Infantile Spasms Therapeutics market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Oral
• Injection

Segmentation by Application:

• Hospital
• Clinic
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Mallinckrodt
• H. Lundbeck
• Insys Therapeutics
• Orphelia Pharma
• Valerion Therapeutics
• Catalyst Pharmaceuticals
• Anavex Life Sciences
• Retrophin
• GW Pharmaceuticals

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Infantile Spasms Therapeutics Market Size (2020-2031)
  2.1.2 Infantile Spasms Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Infantile Spasms Therapeutics by Country/Region (2020, 2024 & 2031)
2.2 Infantile Spasms Therapeutics Segment by Type
  2.2.1 Oral
  2.2.2 Injection
2.3 Infantile Spasms Therapeutics Market Size by Type
  2.3.1 Infantile Spasms Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Infantile Spasms Therapeutics Market Size Market Share by Type (2020-2025)
2.4 Infantile Spasms Therapeutics Segment by Application
  2.4.1 Hospital
  2.4.2 Clinic
  2.4.3 Other
2.5 Infantile Spasms Therapeutics Market Size by Application
  2.5.1 Infantile Spasms Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Infantile Spasms Therapeutics Market Size Market Share by Application (2020-2025)

3 INFANTILE SPASMS THERAPEUTICS MARKET SIZE BY PLAYER

3.1 Infantile Spasms Therapeutics Market Size Market Share by Player
  3.1.1 Global Infantile Spasms Therapeutics Revenue by Player (2020-2025)
  3.1.2 Global Infantile Spasms Therapeutics Revenue Market Share by Player (2020-2025)
3.2 Global Infantile Spasms Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 INFANTILE SPASMS THERAPEUTICS BY REGION

4.1 Infantile Spasms Therapeutics Market Size by Region (2020-2025)
4.2 Global Infantile Spasms Therapeutics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Infantile Spasms Therapeutics Market Size Growth (2020-2025)
4.4 APAC Infantile Spasms Therapeutics Market Size Growth (2020-2025)
4.5 Europe Infantile Spasms Therapeutics Market Size Growth (2020-2025)
4.6 Middle East & Africa Infantile Spasms Therapeutics Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Infantile Spasms Therapeutics Market Size by Country (2020-2025)
5.2 Americas Infantile Spasms Therapeutics Market Size by Type (2020-2025)
5.3 Americas Infantile Spasms Therapeutics Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Infantile Spasms Therapeutics Market Size by Region (2020-2025)
6.2 APAC Infantile Spasms Therapeutics Market Size by Type (2020-2025)
6.3 APAC Infantile Spasms Therapeutics Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Infantile Spasms Therapeutics Market Size by Country (2020-2025)
7.2 Europe Infantile Spasms Therapeutics Market Size by Type (2020-2025)
7.3 Europe Infantile Spasms Therapeutics Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Infantile Spasms Therapeutics by Region (2020-2025)
8.2 Middle East & Africa Infantile Spasms Therapeutics Market Size by Type (2020-2025)
8.3 Middle East & Africa Infantile Spasms Therapeutics Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET FORECAST

10.1 Global Infantile Spasms Therapeutics Forecast by Region (2026-2031)
  10.1.1 Global Infantile Spasms Therapeutics Forecast by Region (2026-2031)
  10.1.2 Americas Infantile Spasms Therapeutics Forecast
  10.1.3 APAC Infantile Spasms Therapeutics Forecast
  10.1.4 Europe Infantile Spasms Therapeutics Forecast
  10.1.5 Middle East & Africa Infantile Spasms Therapeutics Forecast
10.2 Americas Infantile Spasms Therapeutics Forecast by Country (2026-2031)
  10.2.1 United States Market Infantile Spasms Therapeutics Forecast
  10.2.2 Canada Market Infantile Spasms Therapeutics Forecast
  10.2.3 Mexico Market Infantile Spasms Therapeutics Forecast
  10.2.4 Brazil Market Infantile Spasms Therapeutics Forecast
10.3 APAC Infantile Spasms Therapeutics Forecast by Region (2026-2031)
  10.3.1 China Infantile Spasms Therapeutics Market Forecast
  10.3.2 Japan Market Infantile Spasms Therapeutics Forecast
  10.3.3 Korea Market Infantile Spasms Therapeutics Forecast
  10.3.4 Southeast Asia Market Infantile Spasms Therapeutics Forecast
  10.3.5 India Market Infantile Spasms Therapeutics Forecast
  10.3.6 Australia Market Infantile Spasms Therapeutics Forecast
10.4 Europe Infantile Spasms Therapeutics Forecast by Country (2026-2031)
  10.4.1 Germany Market Infantile Spasms Therapeutics Forecast
  10.4.2 France Market Infantile Spasms Therapeutics Forecast
  10.4.3 UK Market Infantile Spasms Therapeutics Forecast
  10.4.4 Italy Market Infantile Spasms Therapeutics Forecast
  10.4.5 Russia Market Infantile Spasms Therapeutics Forecast
10.5 Middle East & Africa Infantile Spasms Therapeutics Forecast by Region (2026-2031)
  10.5.1 Egypt Market Infantile Spasms Therapeutics Forecast
  10.5.2 South Africa Market Infantile Spasms Therapeutics Forecast
  10.5.3 Israel Market Infantile Spasms Therapeutics Forecast
  10.5.4 Turkey Market Infantile Spasms Therapeutics Forecast
10.6 Global Infantile Spasms Therapeutics Forecast by Type (2026-2031)
10.7 Global Infantile Spasms Therapeutics Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Infantile Spasms Therapeutics Forecast

11 KEY PLAYERS ANALYSIS

11.1 Mallinckrodt
  11.1.1 Mallinckrodt Company Information
  11.1.2 Mallinckrodt Infantile Spasms Therapeutics Product Offered
  11.1.3 Mallinckrodt Infantile Spasms Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Mallinckrodt Main Business Overview
  11.1.5 Mallinckrodt Latest Developments
11.2 H. Lundbeck
  11.2.1 H. Lundbeck Company Information
  11.2.2 H. Lundbeck Infantile Spasms Therapeutics Product Offered
  11.2.3 H. Lundbeck Infantile Spasms Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 H. Lundbeck Main Business Overview
  11.2.5 H. Lundbeck Latest Developments
11.3 Insys Therapeutics
  11.3.1 Insys Therapeutics Company Information
  11.3.2 Insys Therapeutics Infantile Spasms Therapeutics Product Offered
  11.3.3 Insys Therapeutics Infantile Spasms Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Insys Therapeutics Main Business Overview
  11.3.5 Insys Therapeutics Latest Developments
11.4 Orphelia Pharma
  11.4.1 Orphelia Pharma Company Information
  11.4.2 Orphelia Pharma Infantile Spasms Therapeutics Product Offered
  11.4.3 Orphelia Pharma Infantile Spasms Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Orphelia Pharma Main Business Overview
  11.4.5 Orphelia Pharma Latest Developments
11.5 Valerion Therapeutics
  11.5.1 Valerion Therapeutics Company Information
  11.5.2 Valerion Therapeutics Infantile Spasms Therapeutics Product Offered
  11.5.3 Valerion Therapeutics Infantile Spasms Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Valerion Therapeutics Main Business Overview
  11.5.5 Valerion Therapeutics Latest Developments
11.6 Catalyst Pharmaceuticals
  11.6.1 Catalyst Pharmaceuticals Company Information
  11.6.2 Catalyst Pharmaceuticals Infantile Spasms Therapeutics Product Offered
  11.6.3 Catalyst Pharmaceuticals Infantile Spasms Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Catalyst Pharmaceuticals Main Business Overview
  11.6.5 Catalyst Pharmaceuticals Latest Developments
11.7 Anavex Life Sciences
  11.7.1 Anavex Life Sciences Company Information
  11.7.2 Anavex Life Sciences Infantile Spasms Therapeutics Product Offered
  11.7.3 Anavex Life Sciences Infantile Spasms Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Anavex Life Sciences Main Business Overview
  11.7.5 Anavex Life Sciences Latest Developments
11.8 Retrophin
  11.8.1 Retrophin Company Information
  11.8.2 Retrophin Infantile Spasms Therapeutics Product Offered
  11.8.3 Retrophin Infantile Spasms Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Retrophin Main Business Overview
  11.8.5 Retrophin Latest Developments
11.9 GW Pharmaceuticals
  11.9.1 GW Pharmaceuticals Company Information
  11.9.2 GW Pharmaceuticals Infantile Spasms Therapeutics Product Offered
  11.9.3 GW Pharmaceuticals Infantile Spasms Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 GW Pharmaceuticals Main Business Overview
  11.9.5 GW Pharmaceuticals Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Infantile Spasms Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Infantile Spasms Therapeutics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Oral
Table 4. Major Players of Injection
Table 5. Infantile Spasms Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Infantile Spasms Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Infantile Spasms Therapeutics Market Size Market Share by Type (2020-2025)
Table 8. Infantile Spasms Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Infantile Spasms Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Infantile Spasms Therapeutics Market Size Market Share by Application (2020-2025)
Table 11. Global Infantile Spasms Therapeutics Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Infantile Spasms Therapeutics Revenue Market Share by Player (2020-2025)
Table 13. Infantile Spasms Therapeutics Key Players Head office and Products Offered
Table 14. Infantile Spasms Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Infantile Spasms Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Infantile Spasms Therapeutics Market Size Market Share by Region (2020-2025)
Table 19. Global Infantile Spasms Therapeutics Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Infantile Spasms Therapeutics Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Infantile Spasms Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Infantile Spasms Therapeutics Market Size Market Share by Country (2020-2025)
Table 23. Americas Infantile Spasms Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Infantile Spasms Therapeutics Market Size Market Share by Type (2020-2025)
Table 25. Americas Infantile Spasms Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Infantile Spasms Therapeutics Market Size Market Share by Application (2020-2025)
Table 27. APAC Infantile Spasms Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Infantile Spasms Therapeutics Market Size Market Share by Region (2020-2025)
Table 29. APAC Infantile Spasms Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Infantile Spasms Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Infantile Spasms Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Infantile Spasms Therapeutics Market Size Market Share by Country (2020-2025)
Table 33. Europe Infantile Spasms Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Infantile Spasms Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Infantile Spasms Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Infantile Spasms Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Infantile Spasms Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Infantile Spasms Therapeutics
Table 39. Key Market Challenges & Risks of Infantile Spasms Therapeutics
Table 40. Key Industry Trends of Infantile Spasms Therapeutics
Table 41. Global Infantile Spasms Therapeutics Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Infantile Spasms Therapeutics Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Infantile Spasms Therapeutics Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Infantile Spasms Therapeutics Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Mallinckrodt Details, Company Type, Infantile Spasms Therapeutics Area Served and Its Competitors
Table 46. Mallinckrodt Infantile Spasms Therapeutics Product Offered
Table 47. Mallinckrodt Infantile Spasms Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Mallinckrodt Main Business
Table 49. Mallinckrodt Latest Developments
Table 50. H. Lundbeck Details, Company Type, Infantile Spasms Therapeutics Area Served and Its Competitors
Table 51. H. Lundbeck Infantile Spasms Therapeutics Product Offered
Table 52. H. Lundbeck Infantile Spasms Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. H. Lundbeck Main Business
Table 54. H. Lundbeck Latest Developments
Table 55. Insys Therapeutics Details, Company Type, Infantile Spasms Therapeutics Area Served and Its Competitors
Table 56. Insys Therapeutics Infantile Spasms Therapeutics Product Offered
Table 57. Insys Therapeutics Infantile Spasms Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Insys Therapeutics Main Business
Table 59. Insys Therapeutics Latest Developments
Table 60. Orphelia Pharma Details, Company Type, Infantile Spasms Therapeutics Area Served and Its Competitors
Table 61. Orphelia Pharma Infantile Spasms Therapeutics Product Offered
Table 62. Orphelia Pharma Infantile Spasms Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Orphelia Pharma Main Business
Table 64. Orphelia Pharma Latest Developments
Table 65. Valerion Therapeutics Details, Company Type, Infantile Spasms Therapeutics Area Served and Its Competitors
Table 66. Valerion Therapeutics Infantile Spasms Therapeutics Product Offered
Table 67. Valerion Therapeutics Infantile Spasms Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Valerion Therapeutics Main Business
Table 69. Valerion Therapeutics Latest Developments
Table 70. Catalyst Pharmaceuticals Details, Company Type, Infantile Spasms Therapeutics Area Served and Its Competitors
Table 71. Catalyst Pharmaceuticals Infantile Spasms Therapeutics Product Offered
Table 72. Catalyst Pharmaceuticals Infantile Spasms Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Catalyst Pharmaceuticals Main Business
Table 74. Catalyst Pharmaceuticals Latest Developments
Table 75. Anavex Life Sciences Details, Company Type, Infantile Spasms Therapeutics Area Served and Its Competitors
Table 76. Anavex Life Sciences Infantile Spasms Therapeutics Product Offered
Table 77. Anavex Life Sciences Infantile Spasms Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Anavex Life Sciences Main Business
Table 79. Anavex Life Sciences Latest Developments
Table 80. Retrophin Details, Company Type, Infantile Spasms Therapeutics Area Served and Its Competitors
Table 81. Retrophin Infantile Spasms Therapeutics Product Offered
Table 82. Retrophin Infantile Spasms Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Retrophin Main Business
Table 84. Retrophin Latest Developments
Table 85. GW Pharmaceuticals Details, Company Type, Infantile Spasms Therapeutics Area Served and Its Competitors
Table 86. GW Pharmaceuticals Infantile Spasms Therapeutics Product Offered
Table 87. GW Pharmaceuticals Infantile Spasms Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. GW Pharmaceuticals Main Business
Table 89. GW Pharmaceuticals Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Infantile Spasms Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Infantile Spasms Therapeutics Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Infantile Spasms Therapeutics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Infantile Spasms Therapeutics Sales Market Share by Country/Region (2024)
Figure 8. Infantile Spasms Therapeutics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Infantile Spasms Therapeutics Market Size Market Share by Type in 2024
Figure 10. Infantile Spasms Therapeutics in Hospital
Figure 11. Global Infantile Spasms Therapeutics Market: Hospital (2020-2025) & ($ millions)
Figure 12. Infantile Spasms Therapeutics in Clinic
Figure 13. Global Infantile Spasms Therapeutics Market: Clinic (2020-2025) & ($ millions)
Figure 14. Infantile Spasms Therapeutics in Other
Figure 15. Global Infantile Spasms Therapeutics Market: Other (2020-2025) & ($ millions)
Figure 16. Global Infantile Spasms Therapeutics Market Size Market Share by Application in 2024
Figure 17. Global Infantile Spasms Therapeutics Revenue Market Share by Player in 2024
Figure 18. Global Infantile Spasms Therapeutics Market Size Market Share by Region (2020-2025)
Figure 19. Americas Infantile Spasms Therapeutics Market Size 2020-2025 ($ millions)
Figure 20. APAC Infantile Spasms Therapeutics Market Size 2020-2025 ($ millions)
Figure 21. Europe Infantile Spasms Therapeutics Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Infantile Spasms Therapeutics Market Size 2020-2025 ($ millions)
Figure 23. Americas Infantile Spasms Therapeutics Value Market Share by Country in 2024
Figure 24. United States Infantile Spasms Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Infantile Spasms Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Infantile Spasms Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Infantile Spasms Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Infantile Spasms Therapeutics Market Size Market Share by Region in 2024
Figure 29. APAC Infantile Spasms Therapeutics Market Size Market Share by Type (2020-2025)
Figure 30. APAC Infantile Spasms Therapeutics Market Size Market Share by Application (2020-2025)
Figure 31. China Infantile Spasms Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Infantile Spasms Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Infantile Spasms Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Infantile Spasms Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 35. India Infantile Spasms Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Infantile Spasms Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Infantile Spasms Therapeutics Market Size Market Share by Country in 2024
Figure 38. Europe Infantile Spasms Therapeutics Market Size Market Share by Type (2020-2025)
Figure 39. Europe Infantile Spasms Therapeutics Market Size Market Share by Application (2020-2025)
Figure 40. Germany Infantile Spasms Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 41. France Infantile Spasms Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Infantile Spasms Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Infantile Spasms Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Infantile Spasms Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Infantile Spasms Therapeutics Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Infantile Spasms Therapeutics Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Infantile Spasms Therapeutics Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Infantile Spasms Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Infantile Spasms Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Infantile Spasms Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Infantile Spasms Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Infantile Spasms Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Infantile Spasms Therapeutics Market Size 2026-2031 ($ millions)
Figure 54. APAC Infantile Spasms Therapeutics Market Size 2026-2031 ($ millions)
Figure 55. Europe Infantile Spasms Therapeutics Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Infantile Spasms Therapeutics Market Size 2026-2031 ($ millions)
Figure 57. United States Infantile Spasms Therapeutics Market Size 2026-2031 ($ millions)
Figure 58. Canada Infantile Spasms Therapeutics Market Size 2026-2031 ($ millions)
Figure 59. Mexico Infantile Spasms Therapeutics Market Size 2026-2031 ($ millions)
Figure 60. Brazil Infantile Spasms Therapeutics Market Size 2026-2031 ($ millions)
Figure 61. China Infantile Spasms Therapeutics Market Size 2026-2031 ($ millions)
Figure 62. Japan Infantile Spasms Therapeutics Market Size 2026-2031 ($ millions)
Figure 63. Korea Infantile Spasms Therapeutics Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Infantile Spasms Therapeutics Market Size 2026-2031 ($ millions)
Figure 65. India Infantile Spasms Therapeutics Market Size 2026-2031 ($ millions)
Figure 66. Australia Infantile Spasms Therapeutics Market Size 2026-2031 ($ millions)
Figure 67. Germany Infantile Spasms Therapeutics Market Size 2026-2031 ($ millions)
Figure 68. France Infantile Spasms Therapeutics Market Size 2026-2031 ($ millions)
Figure 69. UK Infantile Spasms Therapeutics Market Size 2026-2031 ($ millions)
Figure 70. Italy Infantile Spasms Therapeutics Market Size 2026-2031 ($ millions)
Figure 71. Russia Infantile Spasms Therapeutics Market Size 2026-2031 ($ millions)
Figure 72. Egypt Infantile Spasms Therapeutics Market Size 2026-2031 ($ millions)
Figure 73. South Africa Infantile Spasms Therapeutics Market Size 2026-2031 ($ millions)
Figure 74. Israel Infantile Spasms Therapeutics Market Size 2026-2031 ($ millions)
Figure 75. Turkey Infantile Spasms Therapeutics Market Size 2026-2031 ($ millions)
Figure 76. Global Infantile Spasms Therapeutics Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Infantile Spasms Therapeutics Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Infantile Spasms Therapeutics Market Size 2026-2031 ($ millions)